trial · primary record
Disulfiram (DSF)
Brain (Nervous System) Cancers
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Reduction in Complement Immunosuppressive program |
| Registry ID | NCT07719127 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:10.821Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07719127
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.